Cardiac Biotech CBSC Stock
Cardiac Biotech Price Chart
Cardiac Biotech CBSC Financial and Trading Overview
| Cardiac Biotech stock price | 0.04 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | 0.03 USD x 1000000 |
| Ask | 0.04 USD x 2000000 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.02 - 0.06 USD |
| Volume | 19.73K USD |
| Avg. Volume | 16.65K USD |
| Market Cap | 6.45M USD |
| Beta (5Y Monthly) | 1.858 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CBSC Valuation Measures
| Enterprise Value | 2.31M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 128.09418 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 45.938 |
| Enterprise Value/EBITDA | -3.23 |
Trading Information
Cardiac Biotech Stock Price History
| Beta (5Y Monthly) | 1.858 |
| 52-Week Change | -17.021% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.04 USD |
| 200-Day Moving Average | 0.04 USD |
CBSC Share Statistics
| Avg. Volume (3 month) | 16.65K USD |
| Avg. Daily Volume (10-Days) | 8.22K USD |
| Shares Outstanding | 165.44M |
| Float | 48.84M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2018 |
| Most Recent Quarter (mrq) | March 31, 2018 |
| Next Fiscal Year End | March 31, 2019 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3446.97% |
| Gross Margin | 54.34% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 50.37K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 27.37K USD |
| EBITDA | -716355 USD |
| Net Income Avi to Common (ttm) | -640547 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.67K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.029 |
| Book Value Per Share (mrq) | -0.024 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Cardiac Biotech
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 10845 Griffith Peak Drive |
| ZIP | 89135 |
| Phone | 888-225-0870 |
| Website | https://cardiacbiotech.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.
Q&A For Cardiac Biotech Stock
What is a current CBSC stock price?
Cardiac Biotech CBSC stock price today per share is 0.04 USD.
How to purchase Cardiac Biotech stock?
You can buy CBSC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cardiac Biotech?
The stock symbol or ticker of Cardiac Biotech is CBSC.
Which industry does the Cardiac Biotech company belong to?
The Cardiac Biotech industry is Medical Instruments & Supplies.
How many shares does Cardiac Biotech have in circulation?
The max supply of Cardiac Biotech shares is 165.44M.
What is Cardiac Biotech Price to Earnings Ratio (PE Ratio)?
Cardiac Biotech PE Ratio is now.
What was Cardiac Biotech earnings per share over the trailing 12 months (TTM)?
Cardiac Biotech EPS is -0.01 USD over the trailing 12 months.
Which sector does the Cardiac Biotech company belong to?
The Cardiac Biotech sector is Healthcare.